Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TransMedics (TMDX) Net Margin (2018 - 2025)

Historic Net Margin for TransMedics (TMDX) over the last 8 years, with Q3 2025 value amounting to 16.92%.

  • TransMedics' Net Margin rose 130400.0% to 16.92% in Q3 2025 from the same period last year, while for Sep 2025 it was 16.62%, marking a year-over-year increase of 85700.0%. This contributed to the annual value of 8.03% for FY2024, which is 185400.0% up from last year.
  • Per TransMedics' latest filing, its Net Margin stood at 16.92% for Q3 2025, which was up 130400.0% from 22.17% recorded in Q2 2025.
  • In the past 5 years, TransMedics' Net Margin ranged from a high of 22.17% in Q2 2025 and a low of 239.46% during Q3 2021
  • For the 5-year period, TransMedics' Net Margin averaged around 38.98%, with its median value being 6.34% (2023).
  • Per our database at Business Quant, TransMedics' Net Margin plummeted by -1756500bps in 2021 and then skyrocketed by 2105500bps in 2022.
  • TransMedics' Net Margin (Quarter) stood at 149.91% in 2021, then surged by 85bps to 22.22% in 2022, then skyrocketed by 120bps to 4.51% in 2023, then rose by 25bps to 5.65% in 2024, then soared by 199bps to 16.92% in 2025.
  • Its last three reported values are 16.92% in Q3 2025, 22.17% for Q2 2025, and 19.53% during Q1 2025.